Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System.

Certain anticancer agents should be considered risk factors for ED. Our results provide possible treatment strategies for maintaining erectile function in cancer survivors, including careful erectile function monitoring after treatment.